Straumann Holding AG SG&A Expenses 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly sg&a expenses history and growth rate from 2012 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Straumann Holding AG sg&a expenses for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Straumann Holding AG sg&a expenses for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual sg&a expenses for 2024 were $1.36B, a 11.74% decline from 2023.
  • Straumann Holding AG annual sg&a expenses for 2023 were $1.541B, a 20.11% increase from 2022.
  • Straumann Holding AG annual sg&a expenses for 2022 were $1.283B, a 16.84% increase from 2021.
Straumann Holding AG Annual SG&A Expenses
(Millions of US $)
2024 $1,360
2023 $1,541
2022 $1,283
2021 $1,098
2020 $951
2019 $832
2018 $695
2017 $569
2016 $501
2015 $463
2014 $451
2013 $456
2012 $504
2011 $467
Straumann Holding AG Quarterly SG&A Expenses
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.515B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47